The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer
Open accessAbstract
OBJECTIVE: To investigate whether young age at diagnosis is a negative prognostic factor in primary breast cancer and how stage of disease at diagnosis and treatment influences such an association. DESIGN: Retrospective cohort study based on a population based database of patients with breast cancer containing detailed information on tumour characteristics, treatment regimens, and survival. SETTING: Denmark. SUBJECTS: 10 356 women with primary breast cancer who were less than 50 years old at diagnosis. MAIN OUTCOME MEASURES: Relative risk of dying within the first 10 years after diagnosis according to age at diagnosis after adjustment for known prognostic factors and expected mortality. RESULTS: Overall, young women with low risk disease who did not receive adjuvant treatment had a significantly increased risk of dying; risk increased with decreasing age at diagnosis (adjusted relative risk: 45-49 years (reference): 1; 40-44 years: 1.12 (95% confidence interval 0.89 to 1.40); 35-39 years: 1.40 (1.10 to 1.78); <35 years: 2.18 (1.64 to 2.89). However, no similar trend was seen in patients who received adjuvant cytotoxic treatment. The increased risk in younger women who did not receive adjuvant treatment compared with those who did remained when women were grouped according to presence of node negative disease and by tumour size. CONCLUSION: The negative prognostic effect of young age is almost exclusively seen in women diagnosed with low risk disease who did not receive adjuvant cytotoxic treatment. These results suggest that young women with breast cancer, on the basis of age alone, should be regarded as high risk patients and be given adjuvant cytotoxic treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
Early Breast Cancer Trialist's Collaborative Group (1992) · The Lancet · doi:10.1016/0140-6736(92)90997-h · Cited by 2,182
Early Breast Cancer Trialists’ Collaborative Group, & Peto, R. (1993) · Recent Results in Cancer Research · doi:10.1007/978-3-642-84745-5_21 · Cited by 958
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., Säve-Söderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., & Reed, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.7.1049 · Cited by 838
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Wood, W. C., Senn, H.-J., Glick, J. H., & Gelber, R. D. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.19.1441 · Cited by 689
Cancer Registration: Principles and Methods
Jensen, O. M. (1991) · Medical Entomology and Zoology · Cited by 673
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., & Senn, H.-J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3817 · Cited by 582
Nixon, A. J., Neuberg, D., Hayes, D. F., Gelman, R., Connolly, J. L., Schnitt, S., Abner, A., Recht, A., Vicini, F., & Harris, J. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.888 · Cited by 579
The Relation between Survival and Age at Diagnosis in Breast Cancer
Adami, H.-O., Malker, B., Holmberg, L., Persson, I., & Stone, B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150906 · Cited by 549
Tamoxifen and Chemotherapy for Lymph Node-Negative, Estrogen Receptor-Positive Breast Cancer
Fisher, B., Dignam, J., Emir, B., Bryant, J., DeCillis, A., Wolmark, N., Wickerham, D. L., Dimitrov, N. V., Abramson, N., Atkins, J. N., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.22.1673 · Cited by 521
Fourquet, A., Campana, F., Zafrani, B., Mosseri, V., Vielh, P., Durand, J.-C., & Vilcoq, J. R. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90057-6 · Cited by 509
Age as prognostic factor in premenopausal breast carcinoma
de la Rochefordière, A., Campana, F., Fenton, J., Vilcoq, J. R., Fourquet, A., Asselain, B., Scholl, S. M., Pouillart, P., Durand, J.-C., & Magdelenat, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92407-k · Cited by 480
Bergh, J., Norberg, T., Sjögren, S., Lindgren, A., & Holmberg, L. (1995) · Nature Medicine · doi:10.1038/nm1095-1029 · Cited by 460
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Love, R. R., Goldhirsch, A., Glick, J. H., Gelber, R. D., Coates, A. S., & Senn, H.-J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.7.1955 · Cited by 414
Younger women with breast carcinoma have a poorer prognosis than older women
Chung, M., Chang, H. R., Bland, K. I., & Wanebo, H. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1<97::aid-cncr16>3.0.co;2-3 · Cited by 382
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer
Goldhirsch, A., Glick, J. H., Gelber, R. D., & Senn, H.-J. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1601 · Cited by 380
EARLYBREASTCANCERTRIALISTSCOL (1992) · The Lancet · doi:10.1016/0140-6736(92)90139-t · Cited by 375
Veronesi, U., Salvadori, B., Luini, A., et al. (1990) · PubMed · Cited by 322
Breast cancer outcome and predictors of outcome: are there age differentials?
Albain, K. S., Allred, D. C., & Clark, G. M. (1994) · PubMed · Cited by 264
The influence of young age on outcome in early stage breast cancer
Fowble, B. L., Schultz, D. J., Overmoyer, B., Solin, L. J., Fox, K., Jardines, L., Orel, S., & Glick, J. H. (1994) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(94)90515-0 · Cited by 241
Boyages, J., Recht, A., Connolly, J. L., Schnitt, S. J., Gelman, R., Kooy, H., Love, S., Osteen, R. T., Cady, B., Silver, B., et al. (1990) · Radiotherapy and Oncology · doi:10.1016/0167-8140(90)90163-q · Cited by 224
Breast carcinomas occurring in young women (< 35 years) are different
Walker, R., Lees, E., Webb, M., & Dearing, S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.632 · Cited by 220
Induced Abortion and the Risk of Breast Cancer
Melbye, M., Wohlfahrt, J., Olsen, J. H., Frisch, M., Westergaard, T., Helweg-Larsen, K., & Andersen, P. K. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360201 · Cited by 210
Winchester, D. P., Osteen, R. T., & Menck, H. R. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19961015)78:8<1838::aid-cncr27>3.0.co;2-y · Cited by 194
Age as a prognostic factor in breast cancer: Relationship to pathologic and biologic features
Bonnier, P., Romain, S., Charpin, C., Lejeune, C., Tubiana-Mathieu, N., Martin, P., & Piana, L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620205 · Cited by 174
Storm, H. H. (1991) · PubMed · Cited by 106
Conservative treatment of early breast cancer
Baeza, M. R., Solé, J., León, A., et al. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90088-0 · Cited by 103
Phillips, K., Andrulis, I. L., & Goodwin, P. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3653 · Cited by 93
International consensus panel on the treatment of primary breast cancer
Goldhirsch, A., Wood, W. C., Senn, H.-J., Glick, J. H., & Gelber, R. D. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00479-3 · Cited by 73
Risk factors and 10-year breast cancer survival in Northern Alberta
LEES, A. W., Jenkins, H., May, C., Cherian, G., Lam, E. W. H., & Hanson, J. (1989) · Breast Cancer Research and Treatment · doi:10.1007/bf01806526 · Cited by 71
Williams, T. I. (1995) · Endeavour · doi:10.1016/0160-9327(95)90078-0 · Cited by 41
Improved survival in young women with breast cancer
Anderson, B. O., Senie, R. T., Vetto, J. T., Wong, G. Y., McCormick, B. L., & Borgen, P. I. (1995) · Annals of Surgical Oncology · doi:10.1007/bf02306373 · Cited by 41
Are breast cancers in young women qualitatively distinct?
Henderson, I. C., & Patek, A. J. (1997) · The Lancet · doi:10.1016/s0140-6736(97)22021-0 · Cited by 27
Cited by
van der Hage, J. A., van de Velde, C. J. H., Julien, J.-P., Tubiana-Hulin, M., Vandervelden, C., Duchateau, L., & Cooperating Investigators (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.22.4224 · Cited by 1,107
Chronic post-surgical pain: 10 years on
Macrae, W. A. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen099 · Cited by 992
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm271 · Cited by 944
Breast Cancer Before Age 40 Years
Anders, C. K., Johnson, R., Litton, J., Phillips, M., & Bleyer, A. (2009) · Seminars in Oncology · doi:10.1053/j.seminoncol.2009.03.001 · Cited by 791
Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.576 · Cited by 697
Metadata
- Authors
- Kroman, N.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2000-02-19
- Volume
- 320
- Issue
- 7233
- Pages
- 474-479
- ISSN
- 0959-8138 (ISSN-L)
- OpenAlex
- W1567156145
- Cited by
- 373
- References
- 34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.